期刊文献+

大鼠DENA诱癌过程中肝脏维生素K依赖性羧化酶和血浆异常凝血酶原的关系 被引量:2

THE RELATIONSHIP BETWEEN HEPATIC VITAMIN K DEPENDENT CARBOXYLASE AND ABNORMAL PLASMA PROTHROMBIN DURING HEPATOCARCINOGENESIS IN RATS
下载PDF
导出
摘要 在二乙基亚硝胺(DENA)诱发大鼠肝癌过程中,维生素K依赖性羧化酶活性呈现先降低、后升高的现象。在诱癌第20周的肝癌结节中羧化酶活性很低。未羧化凝血酶原前体在肝癌结节中大量堆积,已羧化凝血酶原前体也有类似的堆积现象。诱癌过程中血浆异常凝血酶原呈现马鞍形的变化,这与羧化酶的变化密切相关。癌变时血浆异常凝血酶原的升高主要是由于肝脏羧化酶的缺乏所致,维生素K的缺乏仅是次要因素。 During hepatocarcinogenesis induced by diethylnitrosamine (DENA) in rats, a period of decreased vitamin K-dependent carboxylase activity was observed followed by an increased period. Carfboxylase activity wat still lower in hepatoma nodules at the 20th week.As a result of reduced carboxylase activity, underoarboxylated prothrombin precursor accumulated greatly in the hepatoma nodules, with concomitant high concentrations of carboxylated precursor.Thus, the dynamics of abnormal plasma prothrombin showed a saddle-like curve consistent with the development of vitamin K-dependent carboxylase. It might be suggested that the increase of abnormal plasma prothrombin during hepatocaroinogenesis was mainly due to deficiency of vitamin K-dependent oarboxylase in tumor tissue, the deficiency of vitamin K being only a minor factor.
出处 《上海医科大学学报》 CSCD 1991年第4期269-273,共5页 Journal of Fudan University(Medical Science)
基金 国家自然科学基金资助课题(第386092号)
关键词 羧化酶 维生素K 异常凝血酶原 carboxylase vitamin K abnormal prothrombin prothrombin precursor hepatocellular carcinoma
  • 相关文献

同被引文献18

  • 1金冬雁 李孟枫.分子克隆实验指南:第二版[M].北京:科学出版社,1999.919~936.
  • 2Oka H, Tanori A, Kuroki T, et al. Prospective study of alpha-fetoprotein in cirrhoticpatients monitored for development of hepatocellular carcinoma. Hepatology, 1994, 9:61-66.
  • 3Zo L M, Magalotti D, Bianchi G, et al. Efficacy of a surveillance program for early detection of hepatcx:ellular carcinoma. Cancer, 1996, 78:977-985.
  • 4Liaw Y F, Tai D T, Chen T J, et al. Alpha-fetopmtein changes in the course of chronic hepatitis:Relation to bridying hepatic necrosis and hepatocellular carcinoma. Liver, 1986, 6:133-137.
  • 5Malhotra O P. Purification and characterization of dicoumarol-induced prothrombins. Thrombosis Research, 1979, 15 (3-4) :427-463.
  • 6Wallin R, Ptydz H. Purification from bovine blctxi of the warfarin-induced precursor of prothrc-bin.Biochemical and Biophysical Resarch Communication, 1975, 62(2) : 398-406.
  • 7Liebman H A, Futie B C, Tong M J, et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. New England Journal of Medicine, 1984, 310:1 427Z'1 431.
  • 8Miyakawa T, Kajiwam Y, Shimhata A, et al. Vitamin K contents in liver tissue of hepatocellular carcinoma patients. Japanese Journal of Cancer Research, 2000, 91(1) : 68-74,.
  • 9Huisse M G, Leclercq M, Belghiti J, et al. Mechanism of the abnormal vitamin K-dependent gammacarboxylation process in human hepatocellular carcinomas. Cancer, 1994, 74(5): 1 533-1 541.
  • 10Okuda H, Nakanishi T, Takatsu K, et al. Measurement of serum levels of des-gamma-carboxy prothrtanbin in patients with hepatocellular carcinoma by a revised enzyme immunoossay kit with increased sensitivity. Cancer, 1999, 85(4): 812-818.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部